3rd Quarter - Report

PORTERFIELD, FETTIG & SEARS, LLC for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; issues related to Medicare Part D Coverage; HR 6505 Medicare Negotiation and Compulsory Act; HR 6294 REVAMP Act; Conference report to HR 6157.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has advocated and listed herein.

LobbyistCovered position, as disclosed
JEREMY RABINOVITZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6505 (115th), H.R. 6157 (115th), H.R. 6294 (115th)

Government Issues GOV

S. 2482, Foreign Agents Registration Amendments Act of 2018; S.2039, Disclosing Foreign Influence Act; H.R. 4170, Disclosing Foreign Influence Act.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has advocated and listed herein.

LobbyistCovered position, as disclosed
JEREMY RABINOVITZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2482 (115th), S. 2039 (115th), H.R. 4170 (115th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.